Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Accelerate Diagnostics, Inc. (NASDAQ: AXDX).

Full DD Report for AXDX

You must become a subscriber to view this report.


Recent News from (NASDAQ: AXDX)

Tech and consumer goods stock down in premarket trade
The TJX Companies (NYSE: TJX ) -49% . More news on: TJX Companies Inc., MiMedx Group Inc., Infinera Corporation, Stocks on the move, , Top stock market news, Read more ...
Source: SeekingAlpha
Date: November, 07 2018 09:22
Accelerate Diagnostics' (AXDX) CEO Lawrence Mehren on Q3 2018 Results - Earnings Call Transcript
Accelerate Diagnostics, Inc. (AXDX) Q3 2018 Earnings Conference Call November 6, 2018 4:15 PM ET Executives Laura Pierson – Investor Relations Lawrence Mehren – President and Chief Executive Officer Steve Reichling – Chief Financial Officer Analysts Bri...
Source: SeekingAlpha
Date: November, 07 2018 05:20
Accelerate Diagnostics misses by $0.01, misses on revenue
Accelerate Diagnostics (NASDAQ: AXDX ): Q3 GAAP EPS of -$0.41 misses by $0.01 . More news on: Accelerate Diagnostics, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: November, 06 2018 16:08
Accelerate Diagnostics reports Q3 2018 financial results
TUCSON, Ariz. , Nov. 6, 2018 /PRNewswire/ -- Accelerate Diagnostics, Inc. today announced financial results for the quarter ending September 30 , 2018.  The company reported a 40% increase in U.S. instruments placed under commercial contract, and revenue for the quarter of $1.3 mil...
Source: PR Newswire
Date: November, 06 2018 16:01
Report: Developing Opportunities within CMS Energy, International Paper, IBERIABANK, Accelerate Diagnostics, El Paso Electric, and FTI Consulting - Future Expectations, Projections Moving into 2018
NEW YORK, Aug. 08, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of CMS Energy Corporation (NYSE:CMS), International Paper Company (NYSE:IP),...
Source: GlobeNewswire
Date: August, 08 2018 07:45
Accelerate Diagnostics Receives New Innovative Technology Contract from Vizient for the Accelerate Pheno(TM) System
TUCSON, Ariz. , Aug. 7, 2018 /PRNewswire/ -- Accelerate Diagnostics, Inc. announced today that it received an Innovative Technology contract from Vizient, Inc ., the largest member-driven health care performance improvement company in the United States . The contract was based on a...
Source: PR Newswire
Date: August, 07 2018 07:50
Accelerate Diagnostics, Inc. (AXDX) CEO Lawrence Mehren on Q2 2018 Results - Earnings Call Transcript
Accelerate Diagnostics, Inc. (AXDX) Q2 2018 Results Earnings Conference Call August 6, 2018, 04:30 PM ET Executives Laura Pierson - IR Lawrence Mehren - President and CEO Steve Reichling - CFO, CAO and Secretary Analysts Brian Weinstein - William Blair Tycho Peterson - JP...
Source: SeekingAlpha
Date: August, 06 2018 21:45
Accelerate Diagnostics misses by $0.06, misses on revenue
Accelerate Diagnostics (NASDAQ: AXDX ): Q2 EPS of -$0.43 misses by $0.06 . More news on: Accelerate Diagnostics, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: August, 06 2018 16:04
Accelerate Diagnostics reports Q2 2018 financial results
TUCSON, Ariz. , Aug. 6, 2018 /PRNewswire/ -- Accelerate Diagnostics, Inc. today announced financial results for the quarter ending June 30 , 2018.  The company posted revenue of $1.7 million , up 142% from the prior year quarter, and reported a record number of new agreements ...
Source: PR Newswire
Date: August, 06 2018 16:01
Accelerate Diagnostics to Review Second Quarter 2018 Results on August 6th
TUCSON, Ariz., July 19, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today it will host a conference call on Monday, August 6, 2018 to review the company’s second quarter 2018 financial results and commercial progress. President and Chief Executive Officer, Lawr...
Source: GlobeNewswire
Date: July, 19 2018 14:30

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-0823.3522.3523.9522.25266,746
2018-05-1721.7022.1522.2521.65383,301
2017-06-2028.2028.2528.6527.95149,561
2017-06-1927.9528.2528.4027.50231,542
2017-06-1626.9527.9028.081526.764295,327

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1233,09266,22749.9675Short
2018-12-1162,032105,39958.8544Short
2018-12-1033,30967,67049.2227Short
2018-12-0761,864117,56252.6224Short
2018-12-0641,413101,43540.8271Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on AXDX.


About Accelerate Diagnostics, Inc. (NASDAQ: AXDX)

Logo for Accelerate Diagnostics, Inc. (NASDAQ: AXDX)

Not available

 

Contact Information

 

 

Current Management

  • Thomas V. Geimer / CEO, CFO, Secretary
  • David C. Howson / President

Current Share Structure

  • Market Cap: $1,115,327,180 - 05/14/2018
  • Issue and Outstanding: 55,766,359 - 02/23/2018

 


Recent Filings from (NASDAQ: AXDX)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 14 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 10 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 08 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 12 2018
Amendment to a SC 13D filing
Filing Type: SC 13D/AFiling Source: edgar
Filing Date: April, 12 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 28 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: March, 01 2018
Amendment to a SC 13D filing
Filing Type: SC 13D/AFiling Source: edgar
Filing Date: February, 20 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 15 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 14 2018

 

 


Daily Technical Chart for (NASDAQ: AXDX)

Daily Technical Chart for (NASDAQ: AXDX)


Stay tuned for daily updates and more on (NASDAQ: AXDX)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: AXDX)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in AXDX is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of AXDX and does not buy, sell, or trade any shares of AXDX. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/